Search company, investor...
Search
Vapotherm company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

vapotherm.com

Founded Year

1999

Stage

IPO | IPO

Total Raised

$160M

Date of IPO

11/14/2018

Market Cap

0.04B

Stock Price

1.46

About Vapotherm

Vapotherm is a developer and manufacturer of advanced respiratory care technology based in Exeter, New Hampshire. The company develops comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders.

Vapotherm Headquarters Location

100 Domain Drive

Exeter, New Hampshire, 03833,

United States

603-658-0011

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Vapotherm

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vapotherm is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

11,799 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Vapotherm Patents

Vapotherm has filed 60 patents.

The 3 most popular patent topics include:

  • Respiratory therapy
  • Medical equipment
  • Dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/5/2019

9/13/2022

Respiratory therapy, Dosage forms, Drug delivery devices, Medical equipment, Pulmonology

Grant

Application Date

3/5/2019

Grant Date

9/13/2022

Title

Related Topics

Respiratory therapy, Dosage forms, Drug delivery devices, Medical equipment, Pulmonology

Status

Grant

Latest Vapotherm News

Vapotherm draws downgrade at William Blair after 2Q results

Aug 4, 2022

naphtalina/iStock via Getty Images Vapotherm, Inc. (NYSE: VAPO ), a high-velocity therapy provider targeting patients with respiratory distress, continues to trade sharply lower after the company reported lower-than-expected 2Q 2022 results that prompted William Blair to downgrade its shares. The analysts led by Margaret Kaczor attribute the revenue miss to pressure on disposables as hospitals destocked the inventory purchased during the Omicron wave. However, the team remains optimistic about the benefit Vapotherm ( VAPO ) can count on due to the sizable installed base established during the COVID. In addition, they highlight the management's long-term strategy to become a patient management company for complex lung disease. However, they downgrade the stock to Market Perform from Outperform, noting the concerns over low liquidity and near-term uncertainty.

Vapotherm Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Vapotherm Rank

  • When was Vapotherm founded?

    Vapotherm was founded in 1999.

  • Where is Vapotherm's headquarters?

    Vapotherm's headquarters is located at 100 Domain Drive, Exeter.

  • What is Vapotherm's latest funding round?

    Vapotherm's latest funding round is IPO.

  • How much did Vapotherm raise?

    Vapotherm raised a total of $160M.

  • Who are the investors of Vapotherm?

    Investors of Vapotherm include QuestMark Partners, Kaiser Permanente Ventures, Gilde Healthcare, Morgenthaler Ventures, Arnerich Massena & Associates and 15 more.

  • Who are Vapotherm's competitors?

    Competitors of Vapotherm include ADVOS, Promedtek, Synapse Biomedical, eNeura Therapeutics, Catheter Connections and 11 more.

You May Also Like

H
Health Care Solutions

Respiratory and infusion therapy for patients at home. Acquired by Lincare Holdings, Inc.

Synapse Biomedical Logo
Synapse Biomedical

Synapse Biomedical (SBI) was founded to commercialize the NeuRx Diaphragm Pacing System (DPS) that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency.

A
Aspire Medical

Aspire Medical is developing a new therapy for treating obstructive sleep apnea.

e
eNeura Therapeutics

eNeura Therapeutics develops the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraines.

P
Pathfinder Therapeutics

Pathfinder Therapeutics (PTI) is the developer of Explorer, an image-guided "GPS" device that enables physicians to accurately and efficiently guide the delivery of cancer therapeutics (usually resection and/or ablation) in soft-tissue organs. Explorer is cleared by the FDA in the category of Intraoperative Soft Tissue Tracking. Scout, the company's advanced 3D planning software, provides highly detailed visual and volumetric information for preoperative assessment, thus enabling clinicians to visualize the site of disease, plan the resection and/or ablation and monitor the resultant effects.

Promedtek Logo
Promedtek

ProMedTek is developing Composite Therapy for problem wounds in the medical device technology market.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.